Heavy Cannabis Users Who Develop Schizophrenia Show Better Cognitive Function Than Non-Users
Schizophrenia patients who were heavy cannabis users before their first psychotic episode showed fewer neurological signs and better cognitive performance than those who did not use heavily, suggesting a different pathway to illness.
Quick Facts
What This Study Found
This study compared 34 schizophrenia patients who reported heavy cannabis use before their first psychotic episode with 27 patients who did not.
The results were counterintuitive: heavy pre-psychosis cannabis users showed significantly fewer neurological soft signs (subtle neurological abnormalities considered markers of early neurodevelopmental impairment) and better cognitive functioning across multiple domains including reaction time, episodic memory, and visuoconstructive abilities.
These findings held after controlling for alcohol and tobacco use. Age and gender did not significantly differ between groups.
The authors interpreted this as evidence that heavy pre-psychosis cannabis use may define a distinct phenotype of schizophrenia. Rather than cannabis simply adding neurotoxic damage on top of existing vulnerability, the pattern suggests cannabis-associated psychosis may represent a different route to schizophrenia that involves less neurodevelopmental impairment but where cannabis provides the additional push toward illness.
Key Numbers
61 patients: 34 heavy pre-psychosis users, 27 non-heavy users. Heavy users showed significantly fewer neurological soft signs (p < 0.003) and better performance on reaction time (p = 0.03), episodic memory (p = 0.04), and visuoconstructive praxis (p = 0.03).
How They Did This
Cross-sectional study of 61 schizophrenia patients (34 heavy pre-psychosis cannabis users, 27 non-heavy users) at a University Hospital and Medical Center. Assessment included the Diagnostic Interview for Genetic Studies, Neurological Evaluation Scale (neurological soft signs), PANSS (psychopathology), and a neurocognitive battery measuring attention, memory, and executive functions.
Why This Research Matters
This study challenges the simple narrative that cannabis damages the brain and causes psychosis. Instead, it suggests there may be at least two pathways to schizophrenia: one driven primarily by neurodevelopmental impairment and one where cannabis triggers psychosis in people with relatively intact neurodevelopment.
The Bigger Picture
If cannabis-associated schizophrenia represents a distinct phenotype, it could respond differently to treatment and have a different prognosis. This has implications for personalized psychiatry and for understanding the heterogeneity of schizophrenia.
What This Study Doesn't Tell Us
Cross-sectional design cannot establish causality. Self-reported cannabis use before psychosis onset may be subject to recall bias. The sample size is relatively small. Patients with heavy cannabis use and better cognition may differ from non-users in unmeasured ways (intelligence, socioeconomic status).
Questions This Raises
- ?Do patients with cannabis-associated psychosis respond differently to antipsychotic treatment?
- ?Would they have developed psychosis without cannabis, or is cannabis the necessary trigger?
- ?Does this phenotype have a different genetic risk profile?
Trust & Context
- Key Stat:
- Heavy pre-psychosis cannabis users had fewer neurological signs and better cognition than non-users with schizophrenia
- Evidence Grade:
- Cross-sectional study with comprehensive neurological and cognitive assessment. Moderate because the sample size is small but the findings are well-controlled and clinically meaningful.
- Study Age:
- Published in 2017.
- Original Title:
- Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
- Published In:
- European archives of psychiatry and clinical neuroscience, 267(7), 629-638 (2017)
- Authors:
- Mallet, Jasmina(4), Ramoz, Nicolas(3), Le Strat, Yann(3), Gorwood, Philip, Dubertret, Caroline
- Database ID:
- RTHC-01445
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Does cannabis cause brain damage that leads to schizophrenia?
This study suggests the relationship is more complex. Schizophrenia patients who used cannabis heavily before their first episode actually showed better brain function than those who did not, suggesting cannabis may trigger psychosis through a different mechanism than the neurodevelopmental pathway.
Is cannabis-related psychosis different from other psychosis?
This study supports that idea. Patients with heavy pre-psychosis cannabis use showed a distinct pattern: fewer neurological abnormalities and better cognitive performance, suggesting a different underlying pathway to psychosis.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-01445APA
Mallet, Jasmina; Ramoz, Nicolas; Le Strat, Yann; Gorwood, Philip; Dubertret, Caroline. (2017). Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?. European archives of psychiatry and clinical neuroscience, 267(7), 629-638. https://doi.org/10.1007/s00406-017-0767-0
MLA
Mallet, Jasmina, et al. "Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?." European archives of psychiatry and clinical neuroscience, 2017. https://doi.org/10.1007/s00406-017-0767-0
RethinkTHC
RethinkTHC Research Database. "Heavy cannabis use prior psychosis in schizophrenia: clinica..." RTHC-01445. Retrieved from https://rethinkthc.com/research/mallet-2017-heavy-cannabis-use-prior
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.